National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023
PB 10 of 2023
made under subsection 99ADHC(2) of the
National Health Act 1953
Compilation No. 19
Compilation date: 1 June 2026
Includes amendments: F2025N01020
About this compilation
This compilation
This is a compilation of the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023 that shows the text of the law as amended and in force on 1 June 2026 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).
Application, saving and transitional provisions
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Presentational changes
The Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.
Self‑repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Contents
1 Name
3 Authority
4 Definitions
5 Floor price of certain brands of pharmaceutical items
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
1 Name
(1) This instrument is the National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023.
(2) This instrument may also be cited as PB 10 of 2023.
3 Authority
This instrument is made under subsection 99ADHC(2) of the National Health Act 1953.
4 Definitions
In this instrument:
Act means the National Health Act 1953.
brand has the same meaning as in Part VII of the Act.
pharmaceutical item has the same meaning as in Part VII of the Act.
5 Floor price of certain brands of pharmaceutical items
For the purposes of subsection 99ADHC(2) of the Act, paragraph 99ADHC(1)(c) of the Act applies to a brand mentioned in column 1 of an item in the following table of a pharmaceutical item that is the drug mentioned in column 2 of that table item, in the form mentioned in column 3 of that table item and with the manner of administration mentioned in column 4 of that table item.
Floor price of certain brands of pharmaceutical items | |||
Column 1 | Column 2 | Column 3 | Column 4 |
Fosamax Plus 70 mg/140 mcg | Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral |
Fosamax Plus | Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral |
PKU squeezie | Amino acid formula with vitamins and minerals without phenylalanine | Oral gel 85 g, 30 (PKU squeezie) | Oral |
Kineret | Anakinra | Injection 100 mg in 0.67 mL single use pre‑filled syringe | Injection |
Atenolol‑AFT | Atenolol | Oral solution 50 mg in 10 ml, 300 ml | Oral |
Atropine Injection (Bridgewest) | Atropine | Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | Injection |
Colazide | Balsalazide | Capsule containing balsalazide sodium 750 mg | Oral |
Bicillin L‑A | Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe | Injection |
Bicillin L‑A | Benzathine benzylpenicillin | Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre‑filled syringe | Injection |
Lax‑Tab | Bisacodyl | Tablet 5 mg | Oral |
Pulmicort Respules | Budesonide | Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 | Inhalation |
Pulmicort Turbuhaler | Budesonide | Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses | Inhalation by Mouth |
Calci‑Tab 600 | Calcium | Tablet 600 mg (as carbonate) | Oral |
Cal‑500 | Calcium | Tablet, chewable, 500 mg (as carbonate) | Oral |
Carboplatin Accord | Carboplatin | Solution for I.V. injection 450 mg in 45 mL | Injection |
Cefazolin‑AFT | Cefazolin | Powder for injection 1 g (as sodium) | Injection |
Largactil | Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection |
Largactil | Chlorpromazine | Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral |
Largactil | Chlorpromazine | Tablet containing chlorpromazine hydrochloride 100 mg | Oral |
Largactil | Chlorpromazine | Tablet containing chlorpromazine hydrochloride 25 mg | Oral |
Ovidrel | Choriogonadotropin alfa | Solution for injection 250 micrograms in 0.5 mL pre‑filled pen | Injection |
Ciloxan | Ciprofloxacin | Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the Ear |
CiloQuin | Ciprofloxacin | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the Eye |
Ciloxan | Ciprofloxacin | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the Eye |
Dantrium | Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
DBL Desferrioxamine Mesilate | Desferrioxamine | Powder for injection containing desferrioxamine mesilate 2 g | Injection |
Cardizem | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
Vasocardol | Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral |
ADT Booster | Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre‑filled syringe | Injection |
Triumeq | Dolutegravir with abacavir and lamivudine | Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg | Oral |
Mayne Pharma Erythromycin | Erythromycin | capsule 250 mg (containing enteric coated pellets) | Oral |
Sandrena | Estradiol | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal |
Estradot 75 | Estradiol | Transdermal patches 1.17 mg, 8 | Transdermal |
Estraderm MX 50 | Estradiol | Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal |
Estradot 100 | Estradiol | Transdermal patches 1.56 mg, 8 | Transdermal |
Estraderm MX 100 | Estradiol | Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal |
Estradot 25 | Estradiol | Transdermal patches 390 micrograms, 8 | Transdermal |
Estraderm MX 25 | Estradiol | Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal |
Estradot 50 | Estradiol | Transdermal patches 780 micrograms, 8 | Transdermal |
Estalis sequi 50/140 | Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal |
Estalis continuous 50/140 | Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal |
Repatha | Evolocumab | Injection 140 mg in 1 mL single use pre‑filled pen | Injection |
Ezalo Composite Pack 10mg+10mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
Ezetimibe ‑ Rosuvastatin Sandoz 10 mg/10 mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
Pharmacor Ezetimibe Rosuvastatin Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
Rosuzet Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
Ezalo Composite Pack 10mg+20mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
Ezetimibe ‑ Rosuvastatin Sandoz 10 mg/20 mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
Pharmacor Ezetimibe Rosuvastatin Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
Rosuzet Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
Ezalo Composite Pack 10mg+40mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
Ezetimibe ‑ Rosuvastatin Sandoz 10 mg/40 mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
Pharmacor Ezetimibe Rosuvastatin Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
Rosuzet Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
Ezalo Composite Pack 10mg+5mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral |
Ezetimibe ‑ Rosuvastatin Sandoz 10 mg/5 mg | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral |
Rosuzet Composite Pack | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral |
Atozet | Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | Oral |
Ezetast | Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | Oral |
Ezetimibe/Atorvastatin GH 10/10 | Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | Oral |
Atozet | Ezetimibe with atorvastatin | Tablet 10 mg‑20 mg | Oral |
Ezetast | Ezetimibe with atorvastatin | Tablet 10 mg‑20 mg | Oral |
Ezetimibe/Atorvastatin GH 10/20 | Ezetimibe with atorvastatin | Tablet 10 mg‑20 mg | Oral |
Atozet | Ezetimibe with atorvastatin | Tablet 10 mg‑40 mg | Oral |
Ezetast | Ezetimibe with atorvastatin | Tablet 10 mg‑40 mg | Oral |
Ezetimibe/Atorvastatin GH 10/40 | Ezetimibe with atorvastatin | Tablet 10 mg‑40 mg | Oral |
Atozet | Ezetimibe with atorvastatin | Tablet 10 mg‑80 mg | Oral |
Ezetast | Ezetimibe with atorvastatin | Tablet 10 mg‑80 mg | Oral |
Ezetimibe/Atorvastatin GH 10/80 | Ezetimibe with atorvastatin | Tablet 10 mg‑80 mg | Oral |
APO‑Fentanyl | Fentanyl | Transdermal patch 12.6 mg | Transdermal |
Fentanyl Sandoz | Fentanyl | Transdermal patch 12.6 mg | Transdermal |
APO‑Fentanyl | Fentanyl | Transdermal patch 16.8 mg | Transdermal |
Fentanyl Sandoz | Fentanyl | Transdermal patch 16.8 mg | Transdermal |
APO‑Fentanyl | Fentanyl | Transdermal patch 2.1 mg | Transdermal |
Fentanyl Sandoz | Fentanyl | Transdermal patch 2.1 mg | Transdermal |
APO‑Fentanyl | Fentanyl | Transdermal patch 4.2 mg | Transdermal |
Fentanyl Sandoz | Fentanyl | Transdermal patch 4.2 mg | Transdermal |
APO‑Fentanyl | Fentanyl | Transdermal patch 8.4 mg | Transdermal |
Fentanyl Sandoz | Fentanyl | Transdermal patch 8.4 mg | Transdermal |
Ferro‑Liquid | Ferrous Sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral |
Flucil | Flucloxacillin | Powder for injection 1 g (as sodium monohydrate) | Injection |
Flucil | Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
Flucil | Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
Leucovorin Calcium (Pfizer Australia Pty Ltd) | Folinic acid | Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection |
Lasix | Furosemide | Oral solution 10 mg per ml, 30 ml | Oral |
Fucidin | Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral |
Nitrolingual Pumpspray | Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
Camino Pro Complete | Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 7 (Camino Pro Complete) | Oral |
PKU Glytactin RTD 15 Lite | Glycomacropeptide and essential amino acids with vitamins and minerals | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite) | Oral |
PKU Glytactin RTD 15 | Glycomacropeptide and essential amino acids with vitamins and minerals | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15) | Oral |
PKU Build 10 | Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 15 g, 30 (PKU Build 10) | Oral |
PKU Build 20 | Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 32 g, 30 (PKU Build 20) | Oral |
Camino Pro Bettermilk | Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 40 g, 30 (Camino Pro Bettermilk) | Oral |
DBL Heparin Sodium | Heparin | Injection 5,000 units (as sodium) in 0.2 ml | Injection |
KetoVie 3:1 | High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie 3:1) | Oral |
KetoVie 4:1 | High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie 4:1) | Oral |
KetoVie Peptide 4:1 | High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie Peptide 4:1) | Oral |
Moduretic | Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
Albey Bee Venom | Insect allergen extract‑honey bee venom | Injection set containing 550 micrograms | Injection |
Hymenoptera Honey Bee Venom | Insect allergen extract‑honey bee venom | Injection set containing 550 micrograms with diluent | Injection |
Albey Paper Wasp Venom | Insect allergen extract‑paper wasp venom | Injection set containing 550 micrograms | Injection |
Hymenoptera Paper Wasp Venom | Insect allergen extract‑paper wasp venom | Injection set containing 550 micrograms with diluent | Injection |
Albey Yellow Jacket Venom | Insect allergen extract‑yellow jacket venom | Injection set containing 550 micrograms | Injection |
Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
Toujeo Solostar | Insulin glargine | Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
Ferrosig | Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection |
Isoleucine 1000 | Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000) | Oral |
Isoleucine 50 | Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50) | Oral |
Presolol 100 | Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral |
APO‑Levetiracetam | Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
Keppra | Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
Kerron | Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
Levetiracetam GH | Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
Levetiracetam‑AFT | Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
APO‑Levetiracetam | Levetiracetam | Tablet 1 g | Oral |
Keppra | Levetiracetam | Tablet 1 g | Oral |
Levactam | Levetiracetam | Tablet 1 g | Oral |
Levetiracetam GH | Levetiracetam | Tablet 1 g | Oral |
Levetiracetam SZ | Levetiracetam | Tablet 1 g | Oral |
Levetiracetam Viatris | Levetiracetam | Tablet 1 g | Oral |
LEVETIRACETAM‑WGR | Levetiracetam | Tablet 1 g | Oral |
Levi 1000 | Levetiracetam | Tablet 1 g | Oral |
NOUMED LEVETIRACETAM | Levetiracetam | Tablet 1 g | Oral |
Mirena | Levonorgestrel | Intrauterine drug delivery system 52 mg | Intrauterine |
Lithicarb | Lithium | Tablet containing lithium carbonate 250 mg | Oral |
Quilonum SR | Lithium | Tablet containing lithium carbonate 450 mg (slow release) | Oral |
OsmoLax | Macrogol 3350 | Powder for oral solution 510 g | Oral |
Provera | Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 100 mg | Oral |
Provera | Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 200 mg | Oral |
Penthrox (Combination Pack) | Methoxyflurane | Liquid for inhalation 999 mg per g, 3 ml (with inhaler) | Inhalation by mouth |
Artige | Methylphenidate | Tablet containing methylphenidate hydrochloride 10 mg | Oral |
Ritalin 10 | Methylphenidate | Tablet containing methylphenidate hydrochloride 10 mg | Oral |
Depo‑Nisolone | Methylprednisolone | Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection |
Metoclopramide HCl Medsurge | Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | Injection |
METOCLOPRAMIDE INJECTION BP | Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | Injection |
Flagyl | Metronidazole | Suppositories 500 mg, 10 | Rectal |
MS‑2 Step | Mifepristone and misoprostol | Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms | Oral |
Carbohydrate Free Mixture | Milk protein and fat formula with vitamins and minerals ‑‑ carbohydrate free | Oral powder 225 g (Carbohydrate Free Mixture) | Oral |
MORPHINE SULFATE 15 mg/1 mL MEDSURGE | Morphine | Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | Injection |
MORPHINE SULFATE 30 mg/1 mL MEDSURGE | Morphine | Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | Injection |
Ordine 10 | Morphine | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 1 mL | Oral |
Ordine 2 | Morphine | Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 1 mL | Oral |
Ordine 5 | Morphine | Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 1 mL | Oral |
Prenoxad | Naloxone | Injection containing naloxone hydrochloride 2 mg in 2 mL pre‑filled syringe | Injection |
Nyxoid | Naloxone | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 | Nasal |
Naprosyn SR1000 | Naproxen | Tablet 1 g (sustained release) | Oral |
Proxen SR 1000 | Naproxen | Tablet 1 g (sustained release) | Oral |
Naprosyn | Naproxen | Tablet 250 mg | Oral |
Naprosyn SR750 | Naproxen | Tablet 750 mg (sustained release) | Oral |
Proxen SR 750 | Naproxen | Tablet 750 mg (sustained release) | Oral |
Anaprox 550 | Naproxen | Tablet containing naproxen sodium 550 mg | Oral |
Crysanal | Naproxen | Tablet containing naproxen sodium 550 mg | Oral |
Noriday 28 Day | Norethisterone | Tablets 350 micrograms, 28 | Oral |
Norimin‑1 28 Day | Norethisterone with ethinylestradiol | Pack containing 21 tablets 1 mg‑35 micrograms and 7 inert tablets | Oral |
Norimin 28 Day | Norethisterone with ethinylestradiol | Pack containing 21 tablets 500 micrograms‑35 micrograms and 7 inert tablets | Oral |
Ditropan | Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral |
Oxytrol | Oxybutynin | Transdermal patches 36 mg, 8 | Transdermal |
Oxycodone BNM | Oxycodone | Capsule containing oxycodone hydrochloride 10 mg | Oral |
OxyNorm | Oxycodone | Capsule containing oxycodone hydrochloride 10 mg | Oral |
Oxycodone BNM | Oxycodone | Capsule containing oxycodone hydrochloride 20 mg | Oral |
OxyNorm | Oxycodone | Capsule containing oxycodone hydrochloride 20 mg | Oral |
Oxycodone BNM | Oxycodone | Capsule containing oxycodone hydrochloride 5 mg | Oral |
OxyNorm | Oxycodone | Capsule containing oxycodone hydrochloride 5 mg | Oral |
Pemetrexed Accord | Pemetrexed | Powder for I.V. infusion 1 g (as disodium) | Injection |
Pemetrexed SUN | Pemetrexed | Powder for I.V. infusion 1 g (as disodium) | Injection |
Neulactil | Periciazine | Tablet 10 mg | Oral |
Neulactil | Periciazine | Tablet 2.5 mg | Oral |
Lyclear | Permethrin | Cream 50 mg per g, 30 g | Application |
Nardil | Phenelzine | Tablet 15 mg (as sulfate) | Oral |
Phenoxymethylpenicillin‑AFT | Phenoxymethylpenicillin | Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL | Oral |
Phenoxymethylpenicillin‑AFT | Phenoxymethylpenicillin | Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL | Oral |
Aspecillin VK | Phenoxymethylpenicillin | Tablet 250 mg phenoxymethylpenicillin (as potassium) | Oral |
Aspecillin VK | Phenoxymethylpenicillin | Tablet 500 mg phenoxymethylpenicillin (as potassium) | Oral |
Elidel | Pimecrolimus | Cream 10 mg per g, 15 g | Application |
Pro‑Cid | Probenecid | Tablet 500 mg | Oral |
Stemetil | Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | Injection |
DBL Promethazine Hydrochloride | Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | Injection |
Aptamil Gold+ Pepti‑Junior | Protein hydrolysate formula with medium chain triglycerides | Oral powder 450 g (Aptamil Gold+ Pepti‑Junior) | Oral |
Teglutik | Riluzole | Oral suspension 50 mg per 10 mL, 300 mL | Oral |
Exelon | Rivastigmine | Capsule 1.5 mg (as hydrogen tartrate) | Oral |
Exelon | Rivastigmine | Capsule 3 mg (as hydrogen tartrate) | Oral |
Exelon | Rivastigmine | Capsule 4.5 mg (as hydrogen tartrate) | Oral |
Exelon | Rivastigmine | Capsule 6 mg (as hydrogen tartrate) | Oral |
Salbutamol Cipla | Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 ml single dose units, 30 | Inhalation |
Salbutamol Cipla | Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 ml single dose units, 30 | Inhalation |
Asmol CFC‑Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Ventolin CFC‑Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Zempreon CFC‑Free with dose counter | Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Eldepryl | Selegiline | Tablet containing selegiline hydrochloride 5 mg | Oral |
PHOSPHATE PHEBRA | Sodium acid phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral |
Micolette | Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate | Enemas 3.125 g‑450 mg‑45 mg in 5 mL, 12 | Rectal |
CIPLA TENOFOVIR + EMTRICITABINE 300/200 | Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral |
TENOFOVIR/EMTRICITABINE 300/200 APX | Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral |
TENOFOVIR/EMTRICITABINE 300/200 ARX | Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral |
Tenofovir/Emtricitabine Sandoz 301/200 | Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil succinate 301 mg with emtricitabine 200 mg | Oral |
Timoptol XE | Timolol | Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL | Application to the Eye |
Timoptol | Timolol | Eye drops 5 mg (as maleate) per mL, 5 mL | Application to the Eye |
TOBI podhaler | Tobramycin | Capsule containing powder for oral inhalation 28 mg (for use in podhaler) | Inhalation by Mouth |
Pfizer Australia Pty Ltd | Tobramycin | Injection 80 mg (as sulfate) in 2 mL (without preservative) | Injection |
Lipistart | Triglycerides ‑ medium chain, formula | Oral powder 400 g (Lipistart) | Oral |
ProZero | Triglycerides, long chain with glucose polymer | Oral liquid 1 L, 6 (ProZero) | Oral |
MCT Oil | Triglycerides, medium chain | Oil 500 ml (MCT Oil) | Oral |
Valine 1000 | Valine with carbohydrate | Sachets of oral powder 4 g containing 1 g valine, 30 (Valine 1000) | Oral |
Valine 50 | Valine with carbohydrate | Sachets of oral powder 4 g containing 50 mg valine, 30 (Valine 50) | Oral |
Epilim Liquid | Valproic acid | Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
Epilim Syrup | Valproic acid | Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
APO‑Sodium Valproate | Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
Epilim EC | Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
Sodium Valproate Sandoz | Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
Valpro EC 200 | Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
Valproate Winthrop EC 200 | Valproic acid | Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
APO‑Sodium Valproate | Valproic acid | Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
Epilim EC | Valproic acid | Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
Sodium Valproate Sandoz | Valproic acid | Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
Valpro EC 500 | Valproic acid | Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
Valproate Winthrop EC 500 | Valproic acid | Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
Vancomycin Juno | Vancomycin | Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection |
Vancomycin Viatris | Vancomycin | Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection |
Endnotes
Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.
The following endnotes are included in every compilation:
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history
Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.
Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.
The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.
The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.
Editorial changes
The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.
If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.
Misdescribed amendments
A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.
If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.
Endnote 2—Abbreviation key
ad = added or inserted | orig = original |
am = amended | p = page(s) |
amdt = amendment | para = paragraph(s)/subparagraph(s) |
C[x] = Compilation No. x | /sub‑subparagraph(s) |
ch = Chapter(s) | pres = present |
cl = clause(s) | prev = previous |
cont. = continued | (prev…) = previously |
def = definition(s) | pt = Part(s) |
Dict = Dictionary | r = regulation(s)/Court rule(s) |
disallowed = disallowed by Parliament | reloc = relocated |
div = Division(s) | renum = renumbered |
ed = editorial change | rep = repealed |
exp = expires/expired or ceases/ceased to have | rs = repealed and substituted |
effect | s = section(s)/subsection(s) |
gaz = gazette | /rule(s)/subrule(s)/order(s)/suborder(s) |
LA = Legislation Act 2003 | sch = Schedule(s) |
LIA = Legislative Instruments Act 2003 | SLI = Select Legislative Instrument |
(md) = misdescribed amendment can be given | SR = Statutory Rules |
effect | sub ch = Sub‑Chapter(s) |
(md not incorp) = misdescribed amendment | sub div = Subdivision(s) |
cannot be given effect | sub pt = Subpart(s) |
mod = modified/modification | underlining = whole or part not |
No. = Number(s) | commenced or to be commenced |
Ord = Ordinance |
|
Endnote 3—Legislation history
Name | Registration | Commencement | Application, saving and transitional provisions |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Determination 2023 (PB 10 of 2023) | 31 May 2023 (F2023N00143) | 1 June 2023 (s 2(1) item 1) |
|
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2023 (PB 104 of 2023) | 5 Oct 2023 (F2023N00372) | sch 1: 6 Oct 2023 (s 2(1) item 2) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2024 (PB 11 of 2024) | 7 Feb 2024 (F2024N00127) | sch 1: 1 June 2024 (s 2(1) item 2) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 2) 2024 (PB 33 of 2024) | 29 Apr 2024 (F2024N00358) | sch 1: 1 Aug 2024 (s 2(1) item 2) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 3) 2024 (PB 65 of 2024) | 17 July 2024 (F2024N00644) | sch 2: 1 Dec 2024 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 4) 2024 (PB 84 of 2024) | 28 Oct 2024 (F2024N01003) | sch 2: 1 Feb 2025 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 5) 2024 (PB 133 of 2024) | 13 Dec 2024 (F2024N01140) | sch 1: 1 Jan 2025 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2025 (PB 21 of 2025) | 21 Feb 2025 (F2025N00158) | sch 1: 1 Aug 2025 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 2) 2025 (PB 39 of 2025) | 16 Apr 2025 (F2025N00326) | sch 2: 1 Oct 2025 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 3) 2025 (PB 67 of 2025) | 11 June 2025 (F2025N00457) | sch 2: 1 Oct 2025 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 4) 2025 (PB 121 of 2025) | 23 Oct 2025 (F2025N00848) | sch 2: 1 Apr 2026 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 5) 2025 (PB 165 of 2025) | 22 Dec 2025 (F2025N01020) | sch 1: 1 June 2026 (s 2(1) item 3) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 1) 2026 (PB 8 of 2026) | 17 Feb 2026 (F2026N00130) | sch 1: 1 Aug 2026 (s 2(1) item 2) | — |
National Health (Floor Price for Certain Brands of Pharmaceutical Items) Amendment Determination (No. 2) 2026 (PB 44 of 2026) | 28 Apr 2026 (F2026N00276) | sch 1: 1 Oct 2026 (s 2(1) item 2) | — |
Endnote 4—Amendment history
Provision affected | How affected |
s 2..................... | rep LA s 48D |
s 5..................... | rs F2023N00372 |
| am F2023N00372; F2024N00127; F2024N00358; F2024N00644; F2024N01003; F2024N01140; F2025N00158; F2025N00326 (sch 1 item 1 md not incorp); F2025N00457; F2025N00848; F2025N01020; F2026N00130; F2026N00276 |